Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US00287Y1091
Ticker ABBV
Company ABBVIE
Currency $
Price
Aware Investor Index (AII) 92.1729
Recommendation STRONG BUY
P/E 80.50
ROE 100.00 %
Capitalization 328,316,720,000 $
Dividend Yield 1.05 %
P/S 14.36
AII Position 41
P/E Position 707
ROE Position 29
Capitalization Position 11
Dividend Yield Position 510
Sales 22,859,000,000 $
10-Year Average Earnings 4,078,250,000 $
Shares Outstanding 1,637,000,000
Equity 3,945,000,000 $
Dividend per Share 2.1 $
Industry Pharmaceutical
Country United States
ABBVIE Investor Relations Web Site http://www.abbvieinvestor.com







Sales:

YEAR MONTH AMOUNT
2015 12 22,859,000,000.00 $
2014 12 19,960,000,000.00 $
2013 12 18,790,000,000.00 $
2012 12 18,380,000,000.00 $
2011 12 17,444,000,000.00 $
2010 12 15,638,000,000.00 $
2009 12 14,214,000,000.00 $
2008 12 14,179,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2015 12 5,144,000,000.00 $
2014 12 1,774,000,000.00 $
2013 12 4,128,000,000.00 $
2012 12 5,275,000,000.00 $
2011 12 3,433,000,000.00 $
2010 12 4,178,000,000.00 $
2009 12 4,636,000,000.00 $
2008 12 4,058,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2015 12 3,945,000,000.00 $
2014 12 1,742,000,000.00 $
2013 12 4,492,000,000.00 $
2012 12 3,363,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2015 12 1,637,000,000
2014 12 1,610,000,000
2013 12 1,604,000,000
2012 12 1,577,000,000

 












Bloomberg News for ABBVIE:

Apr 26, 2017
Two-Day Stock Rally Pauses as Trump Tax Plan Details Unfold
Group Inc (AAL), BorgWarner Inc (BWA), Xcel Energy Inc (XEL), Teradata Corp (TDC), AbbVie Inc (ABBV), American Electric Power Co Inc (AEP), Boston Scientific Corp (BSX), Southwest Airlines Co (LUV)...
Mar 21, 2017
Goldman Says These Dividend Stocks Will Do Well Even With the Fed Hiking Rates
WHR, HD, LOW, PHM, MO, RAI, ADM, CVS, MJN, VLO, PSX, MPC, TSO, LM, HBAN, KEY, MMC, MS, BEN, UNM, ABBV, PFE, AMGN, CAH, MDT, ABT, DGX, BA, NLSN, ITW, HON, IR, CSCO, XRX, HPQ, IBM, TXN, MSI, MSFT, GLW...
Jun 12, 2013
Positive EPS Surprises for First Quarter of ’13 for S&P 500
62 1.6 Mar 4/30 EQR Equity Residential 0.64 0.61 4.9 0.63 1.6 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 4/25 CELG Celgene Corp ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Sectors
4.8 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
Jun 12, 2013
EPS in the First Quarter of ’13 for S&P 500 Stocks by Industry
8.6 Mar 4/23 AMGN Amgen Inc 1.96 1.61 21.7 1.84 6.5 Mar 4/26 ABBV AbbVie Inc. 0.68 0.56 21.4 0.67 1.5 Mar 5/2 ACT Actavis Inc ...
May 16, 2013
And the Winner of the Top Student-Run Investment Fund Is ...
Apache (APA), -15.42 percent UnitedHealth Group (UNH), -2.52 percent AbbVie (ABBV), -2.39 percent FIXED INCOME First Place: Stetson University...
Nov 14, 2014
Maverick Capital Ltd Holdings in 3rd Quarter: 13F Alert
Plc-Series C LBTYK US 279,296,113 6,809,609 238,560 AbbVie Inc ABBV US 272,833,865 4,723,578 1,488,445 CBS Corp-Class B Non Voting CBS US 258,296...
Dec 10, 2012
Abbott Spinoff AbbVie Begins Trading to Determine Value
percent to $30.30 at 4 p.m. New York time. AbbVie when-issued shares, trading under the ticker ABBV-W, opened at $37 and fell 5.4 percent to $35. The secondary market for the when-issued shares...
Feb 14, 2013
SAC Capital Advisors Holdings in 4th Quarter: 13F Alert
Alcatel-Lucent-Sponsored ADR ALU US 54,244,194 39,024,600 39,024,600 AbbVie Inc ABBV US 51,877,221 1,518,654 1,518,654 Analog Devices Inc ADI US 47,426...
May 3, 2013
S&P 500 Stocks Biggest Weekly Changes in Target Price
44.58 42.09 3.526 THC TENET HEALTHCAR 5.90 14 49.18 46.44 4.043 ABBV ABBVIE INC 5.85 6 46.22 43.67 3.800 TWX TIME WARNER INC 5...


Google News for ABBVIE:

Seeking Alpha - 2 days ago
AbbVie May Have Found Something
Much has been written about AbbVie (NYSE:ABBV) and its dependence on the revenues of its blockbuster, HUMIRA, but not much is ever ...
Yahoo Finance - 5 days ago
What's in Store for AbbVie (ABBV) this Earnings Season?
AbbVie Inc. ABBV is slated to release first-quarter 2017 earnings, before the opening ... AbbVie Inc. Price and EPS Surprise | AbbVie Inc. Quote.
Seeking Alpha - 1 day ago
AbbVie: Pursuing Outperformance With This Undervalued ...
This first company-specific article will discuss AbbVie, Inc. (NYSE:ABBV), which in recent months has not received the love that I believe it ...
The Cerbat Gem
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
AbbVie Inc. ABBV recently announced disappointing top-line results from two phase III studies evaluating its PARP inhibitor, veliparib in ...
StockNewsJournal
AbbVie (ABBV) Shares Cross 4% Yield Mark
Looking at the universe of stocks we cover at Dividend Channel , in trading on Tuesday, shares of AbbVie Inc (Symbol: ABBV) were yielding ...
HugoPress
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
AbbVie Inc. ABBV announced that data from two phase III studies, EXPEDITION-1 and ENDURANCE-3, evaluating its investigational, ...
Yahoo Finance - 6 days ago
AbbVie (ABBV) Reports High SVR12 Rates with 8 Weeks Treatment ...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced high SVR12 rates were achieved with 8 weeks of treatment ...
Barron's (blog)
AbbVie (ABBV) G/P Achieved 99% SVR(12) Rate in Chronic ...
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that 99 percent (n=145/146) of chronic hepatitis C virus (HCV) ...
StreetInsider.com
Financial Engines Advisors Has Trimmed Abbvie (ABBV) Holding, 6 ...
Financial Engines Advisors Llc decreased Abbvie Inc (ABBV) stake by 4.45% reported in 2016Q4 SEC filing. Financial Engines Advisors Llc ...
Seeking Alpha
AbbVie (ABBV): Still Concerned About Long Term - BMO
BMO Capital analyst, Alex Arfaei, reiterated his Market Perform rating on shares of Abbvie (NYSE: ABBV) along with his market level $63 price ...


Back